BioMaxima S.A. (WSE:BMX)
Poland · Delayed Price · Currency is PLN 10.10
+0.06 (0.60%)
Sep 4, 2026, 5:00 PM CET
BioMaxima Market Cap
BioMaxima has a market cap or net worth of 42.35 million as of September 4, 2026. Its market cap has decreased by -21.09% in one year.
Market Cap
42.35M
Enterprise Value
58.05M
Revenue
59.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.10
ChartMarket Cap Chart
Since July 21, 2010, BioMaxima's market cap has increased from 11.40M to 42.35M, an increase of 271.38%. That is a compound annual growth rate of 8.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 42.35M | -16.18% |
| Dec 30, 2025 | 50.53M | 12.62% |
| Dec 30, 2024 | 44.87M | -34.84% |
| Dec 29, 2023 | 68.85M | -35.28% |
| Dec 30, 2022 | 106.38M | -6.37% |
| Dec 30, 2021 | 113.62M | -4.71% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.68B |
| NEUCA | 3.50B |
| Synektik Spólka Akcyjna | 2.77B |
| Voxel | 1.43B |
| Read-Gene | 58.95M |
| Genomtec | 54.84M |
| Milton Essex Spólka Akcyjna | 45.82M |
| Pharmena | 36.42M |